DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Hauschild A, Grob JJ, Demidov LV. et al.
Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial.
Lancet 2012;
380: 358-365
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.